MAM

Monaco Asset Management Portfolio holdings

AUM $269M
1-Year Est. Return 6.08%
This Quarter Est. Return
1 Year Est. Return
+6.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$269M
AUM Growth
+$4.59M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1 +$15.5M
2 +$12.3M
3 +$7.97M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
+$7.95M
5
ACLX icon
Arcellx
ACLX
+$6.45M

Sector Composition

1 Healthcare 38.55%
2 Materials 18.62%
3 Energy 16.64%
4 Consumer Discretionary 12.41%
5 Communication Services 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRQR icon
51
ProQR Therapeutics
PRQR
$223M
$980K 0.06%
460,000
FATE icon
52
Fate Therapeutics
FATE
$119M
$970K 0.06%
770,000
+95,000
TEO icon
53
Telecom Argentina
TEO
$5.43B
$872K 0.05%
+120,000
OFIX icon
54
Orthofix Medical
OFIX
$628M
$850K 0.05%
58,059
+1,690
PSKY
55
Paramount Skydance Corp
PSKY
$17.3B
$804K 0.05%
+42,500
FET icon
56
Forum Energy Technologies
FET
$369M
$801K 0.05%
30,000
-20,000
ALCO icon
57
Alico
ALCO
$270M
$763K 0.05%
22,005
GT icon
58
Goodyear
GT
$2.48B
$748K 0.05%
100,000
+30,000
RUM icon
59
Rumble
RUM
$2.28B
$724K 0.04%
+100,000
VTYX icon
60
Ventyx Biosciences
VTYX
$669M
$702K 0.04%
225,603
-536,288
PRTA icon
61
Prothena Corp
PRTA
$553M
$683K 0.04%
70,000
QTTB icon
62
Q32 Bio
QTTB
$47M
$616K 0.04%
311,137
-280,800
TVRD
63
Tvardi Therapeutics
TVRD
$36.7M
$530K 0.03%
+13,590
ALGN icon
64
Align Technology
ALGN
$10.5B
$501K 0.03%
+4,000
YPF icon
65
YPF
YPF
$14.3B
$486K 0.03%
+20,000
CC icon
66
Chemours
CC
$1.92B
$475K 0.03%
+30,000
LXRX icon
67
Lexicon Pharmaceuticals
LXRX
$494M
$473K 0.03%
350,000
-181,600
RTAC
68
Renatus Tactical Acquisition Corp I
RTAC
$333M
$443K 0.03%
40,592
-5,000
GGAL icon
69
Galicia Financial Group
GGAL
$8.43B
$413K 0.03%
+15,000
TDW icon
70
Tidewater
TDW
$2.72B
$292K 0.02%
+5,469
AAPL icon
71
Apple
AAPL
$4.18T
0
ABBV icon
72
AbbVie
ABBV
$398B
0
AZO icon
73
AutoZone
AZO
$65.6B
0
BMO icon
74
Bank of Montreal
BMO
$88.9B
0
TECX
75
Tectonic Therapeutic
TECX
$383M
-10,500